Third dose of the COVID-19 vaccine with Dr. Deepali Kumar

Air Date: October 26, 2021 | Length: 28:05

Beate Sander

Share this episode: UHNTwitter UHN Facebook UHN LinkedIn

Episode Description

Transplant patients are among the most vulnerable populations when it comes to COVID-19. A world-first discovery at the Ajmera Transplant Centre at UHN found that a third dose of the COVID-19 vaccine for transplant patients shows substantially improved protection. Dr. Deepali Kumar, joint-senior author on the study, recalls the importance of this groundbreaking discovery for transplant patients.

Dr. Kumar discusses the importance of work-life balance, overcoming obstacles and mentorship in research. She draws on her experience of moving from Saharanpur, a city 200 kilometres north of New Delhi in India to Winnipeg, Manitoba, at the age of nine, and the bravery her parents had to make that big, life-changing decision.

About Dr. Deepali Kumar

Dr. Deepali Kumar in the lab

Dr. Deepali Kumar is a Professor of Medicine, University of Toronto, and Director of Transplant Infectious Diseases at UHN. She is the President-Elect of the American Society of Transplantation, and Chair of the Canadian Standards Association Committee on Cells, Tissues, Organ Transplants. Her clinical and research interests focus on infections in transplant recipients including the impact of viruses and vaccines in this population. Dr. Kumar has published over 200 scientific papers and mentored many trainees. Dr. Kumar has been very involved in COVID research since the start of the pandemic.

Back to Top